Accueil>>tert-Butyl 11-aminoundecanoate

tert-Butyl 11-aminoundecanoate

Catalog No.GC61991

Le 11-aminoundécanoate de tert-butyle (composé 6b) est un lieur PROTAC, qui fait référence À la composition du PEG. Le 11-aminoundécanoate de tert-butyle peut être utilisé dans la synthèse d'une série de PROTAC. Les PROTAC contiennent deux ligands différents reliés par un lieur; l'un est un ligand pour une ligase d'ubiquitine E3 et l'autre est pour la protéine cible. Les PROTAC exploitent le système intracellulaire ubiquitine-protéasome pour dégrader sélectivement les protéines cibles.

Products are for research use only. Not for human use. We do not sell to patients.

tert-Butyl 11-aminoundecanoate Chemical Structure

Cas No.: 220851-29-6

Taille Prix Stock Qté
100 mg
135,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

tert-Butyl 11-aminoundecanoate (compound 6b) is a PROTAC linker, which refers to the PEG composition. tert-Butyl 11-aminoundecanoate can be used in the synthesis of a series of PROTACs. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].

[1]. Kim K, et al. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera. Sci Rep. 2019 Dec 23;9(1):19654.

Avis

Review for tert-Butyl 11-aminoundecanoate

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for tert-Butyl 11-aminoundecanoate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.